ACTA1 and vascular disorder: * Biocompatibility and high electrical conductivity* Intrinsic anti-inflammatory and anti-apoptotic properties* Decreased expression levels of CD86, a co-activator to T-cell activation* Ameliorated loss of medial α-SMA* Reduced early development of allograft vasculopathy